Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

Synergy Pharmaceuticals, Inc. (SGYP)

-NasdaqGM

4.96 Up 0.19(3.98%) Jun 18, 4:00PM EDT|After Hours : 4.96 0.00 (0.00%) Jun 18, 4:31PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development14,344  8,084  8,246  7,626  
Selling General and Administrative3,278  2,448  1,843  1,918  
Non Recurring -  1,000   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (17,622) (11,532) (10,089) (9,544)
Income from Continuing Operations
Total Other Income/Expenses Net(1,075)(445)203  (1,014)
Earnings Before Interest And Taxes(18,697)(11,978)(9,885)(10,558)
Interest Expense -   -   -   -  
Income Before Tax(18,697)(11,978)(9,885)(10,558)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(18,697)(11,978)(9,885)(10,558)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (18,697) (11,978) (9,885) (10,558)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (18,697) (11,978) (9,885) (10,558)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.